BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532 [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522]
URL: https://www.wjgnet.com/1948-5182/full/v13/i5/522.htm
Number Citing Articles
1
Yuriy A. Kravchuk. Features of management of patients with liver diseases in the conditions of the COVID-19 pandemicRussian Military Medical Academy Reports 2021; 40(3): 57 doi: 10.17816/rmmar76270
2
D. I. Trukhan, E. L. Davydov. Liver drug damage: possibilities of polyionic succinate-methioninic complex during the pandemic of new coronavirus infection (COVID-19)Meditsinskiy sovet = Medical Council 2021; (15): 110 doi: 10.21518/2079-701X-2021-15-110-121